[Prevention of Rh immunization. II. Management of the risk during the second half of pregnancy and postpartum].
Larsen
Jørgen Falck
JF
Amtssygehuset i Herlev, Gynaekologisk-Obstetrisk Afdeling, H:S Rigshospitalet, Juliane Marie Centret, Obstetrisk Klinik. falcklarsen@dadlnet.dk
Bock
Johannes E
JE
Jørgensen
Jan R
JR
D005260:Female; D005331:Fetomaternal Transfusion / Q000150:complications / Q000276:immunology; D006801:Humans; D049590:Postpartum Period / Q000276:immunology; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011248:Pregnancy Complications / Q000276:immunology*; D011262:Pregnancy Trimester, Second / Q000276:immunology; D011263:Pregnancy Trimester, Third / Q000276:immunology; D011644:Puerperal Disorders / Q000276:immunology; D012203:Rh Isoimmunization / Q000209:etiology / Q000517:prevention & control*; D018029:Rho(D) Immune Globulin / Q000008:administration & dosage*; D012307:Risk Factors
D018029:Rho(D) Immune Globulin
Forebyggelse af Rhesusimmunisering. II. Imødegåelse af risiko i sidste halvdel af graviditeten og ved fødslen.